Search Within

Myeloma

Formats
  1. Meeting Abstract (557)
  2. Journal Article (368)
  3. Review (37)
  4. Research Letter (21)
  5. Book Section (10)
  6. Guidelines (10)
  7. Correspondence (7)
  8. Editorial (5)
  9. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (1016)
  2. Department of Medicine (1016)
  3. Hematologic Malignancies, Division of (1016)
  4. Hematologic Malignancies Research (669)
  5. Survivorship Research (374)
  6. Sloan Kettering Institute Postdocs (306)

More Groups

People
  1. Alexander Lesokhin (381)
  2. Hani Hassoun (339)
  3. Carl Landgren (336)
  4. Sham Mailankody (297)
  5. Malin Hultcrantz (274)
  6. Heather Landau (249)

More People

Years
  1. 2025 (28)
  2. 2024 (82)
  3. 2023 (115)
  4. 2022 (96)
  5. 2021 (76)
  6. 2020 (95)

More Years

Publications
  1. Blood (317)
  2. Clinical Lymphoma, Myeloma and Leukemia (96)
  3. Journal of Clinical Oncology (86)
  4. Haematologica (41)
  5. Biology of Blood and Marrow Transplantation (29)
  6. Blood Cancer Journal (24)

More Publications

Publishers
  1. American Society of Hematology (340)
  2. Elsevier Inc. (160)
  3. American Society of Clinical Oncology (88)
  4. Nature Publishing Group (87)
  5. Ferrata Storti Foundation (41)
  6. American Association for Cancer Research (34)

More Publishers

Results (1016)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A prospective study of circulating chemokines and angiogenesis markers and risk of multiple myeloma and its precursor
    Meeting Abstract

    Hofmann, J.; Landgren, C. O.; Landy, R.; Kemp, T.; Santo, L.; McShane, C.; Shearer, J.; Lan, Q.; Rothman, N.; Pinto, L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Practice patterns with focal progression on daratumumab therapy
    Meeting Abstract

    Bal, S.; Peterson, T.; Landau, H.; Chung, D.; Giralt, S.; Korde, N.; Mailankody, S.; Smith, E.; Shah, U.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Synthesis, preclinical analysis, and first-in-human phase I imaging of 89Zr-DFO-daratumumab for CD38 targeted imaging of myeloma
    Meeting Abstract

    Ulaner, G.; Sobol, N.; O'Donoghue, J.; Lyashchenko, S.; Lewis, J.; Landgren, C. O.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Fractures and survival in multiple myeloma: Results from a population-based study
    Meeting Abstract

    Thorsteinsdottir, S.; Gislason, G.; Aspelund, T.; Sverrisdottir, I.; Landgren, C. O.; Turesson, I.; Bjorkholm, M.; Kristinsson, S.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Dynamic monitoring of minimal residual disease reveals its superior prognostic significance in multiple myeloma
    Meeting Abstract

    Jin, F. Y.; Landgren, C. O.; Dai, Y.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma
    Meeting Abstract

    Bal, S.; Landau, H.; Shah, G.; Scordo, M.; Dahi, P.; Lahoud, O.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Timing the initiation of multiple myeloma
    Meeting Abstract

    Maura, F.; Rustad, E.; Yellapantula, V.; Bolli, N.; Leongamornlert, D.; Nadeu, F.; Angelopoulos, N.; Dawson, K.; Mitchell, T.; Osborne, R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Updated efficacy and safety of melflufen in patients with relapsed/refractory multiple myeloma refractory to daratumumab and/or pomalidomide: HORIZON (OP-106)
    Meeting Abstract

    Richardson, P. G.; Oriol, A.; Larocca, A.; Rodriguez-Otero, P.; Norkin, M.; Blade, J.; Cavo, M.; Hassoun, H.; Leleu, X.; Alegre, A.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save
  • Cardiac ALL: Most unusual occurrence of lenalidomide-associated acute lymphoblastic leukemia with subsequent cardiac unvolvement
    Journal Article

    Sharma, N.; Hassoun, H.; Hatem, J.; Kouides, P.
    Cureus (2019)

    Fulltext@MSK | Save
  • Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma
    Journal Article

    Rustad, E. H.; Misund, K.; Bernard, E.; Coward, E.; Yellapantula, V. D.; Hultcrantz, M.; Ho, C.; Kazandjian, D.; Korde, N.; Mailankody, S.; more...
    American Journal of Hematology (2019)

    Fulltext@MSK | Save